Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$838K Buy
+22,021
New +$783K ﹤0.01% 3029
2022
Q1
Sell
-207,465
Closed -$4.22M 3408
2021
Q4
$4.22M Sell
207,465
-48,135
-19% -$958K ﹤0.01% 2221
2021
Q3
$4.83M Sell
255,600
-35
-0% -$644 ﹤0.01% 2230
2021
Q2
$4.33M Buy
255,635
+1,200
+0.5% +$20.5K ﹤0.01% 2326
2021
Q1
$4.32M Buy
254,435
+600
+0.2% +$10.3K ﹤0.01% 2232
2020
Q4
$3.93M Sell
253,835
-15
-0% -$212 ﹤0.01% 2196
2020
Q3
$3.18M Buy
253,850
+10,270
+4% +$126K ﹤0.01% 2146
2020
Q2
$3M Sell
243,580
-285
-0.1% -$3.5K ﹤0.01% 2156
2020
Q1
$2.88M Buy
243,865
+2,675
+1% +$42.2K ﹤0.01% 2015
2019
Q4
$4.02M Buy
241,190
+420
+0.2% +$6.74K ﹤0.01% 2104
2019
Q3
$3.62M Sell
240,770
-1,825
-0.8% -$27.4K ﹤0.01% 2130
2019
Q2
$3.63M Buy
+242,595
New +$3.47M ﹤0.01% 2154
2018
Q1
Sell
-14,235
Closed -$241K 1109
2017
Q4
$241K Buy
14,235
+280
+2% +$4.74K ﹤0.01% 1027
2017
Q3
$226K Sell
13,955
-5,820
-29% -$93.6K ﹤0.01% 1048
2017
Q2
$308K Buy
19,775
+5,620
+40% +$87.8K ﹤0.01% 1019
2017
Q1
$213K Buy
+14,155
New +$219K ﹤0.01% 1307

Other funds holding IX

Nuveen's IX Position: Q2 2026 in Review

Nuveen opened a new position in ORIX (IX) in Q2 2026: 22,021 shares worth $838K. The stake represents ﹤0.01% of the portfolio and ranks #3029 among its holdings. This is a return to the name: Nuveen previously reported a position in IX as recently as Q4 2021.

Nuveen first reported a position in IX in Q1 2017 and has held it in 16 quarters since. The position peaked at $4.83M in Q3 2021. 319 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Nuveen held 22,021 shares of ORIX worth $838K as of Q2 2026.
  • ORIX was a new Nuveen position in Q2 2026.
  • ORIX made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3029 holding.
  • Nuveen first reported a position in ORIX in Q1 2017 and has held it in 16 quarters since.
  • Nuveen's ORIX position peaked at $4.83M in Q3 2021.
  • 319 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.